Moullin Joanna C, Sabater-Hernández Daniel, Benrimoj Shalom I
Graduate School of Health, University of Technology Sydney, Level 4, Building 7, 67 Thomas St Ultimo, P.O. Box 123 Broadway, 2007 NSW, Australia.
Graduate School of Health, University of Technology Sydney, Level 4, Building 7, 67 Thomas St Ultimo, P.O. Box 123 Broadway, 2007 NSW, Australia; Academic Centre in Pharmaceutical Care, Pharmaceutical Care Research Group, Faculty of Pharmacy, University of Granada, Campus Universitario de Cartuja s/n, C.P. 18071, Granada, Spain.
Res Social Adm Pharm. 2016 May-Jun;12(3):515-22. doi: 10.1016/j.sapharm.2015.08.003. Epub 2015 Aug 15.
Pharmacy practice and pharmaceutical care research of professional services has largely focused on patient outcomes and cost-effectiveness. Research studies have been, for the most part, conducted in controlled conditions prior to full scale implementation. There appears to be a dearth of process and evaluation of implementation reported. Conducting implementation research or adding implementation measures to an impact study, adds external validity to service and patient outcomes. Evaluations are required for all aspects of implementation including indicators of movement through the implementation stages (formative and summative implementation process evaluation), measures of influencing factors (barriers and facilitators) and change in factors over time (implementation impact), assessment of strategies and/or the implementation program, and overall measures to generate a level of implementation (implementation outcomes). The level of implementation of a professional pharmacy service can be estimated from the level of service delivery (reach and fidelity) and level as a service provider (integration and strength of support in the service environment). The model may be used for evaluating professional pharmacy services and for evaluating implementation programs.
药学实践及专业服务的药学照护研究主要聚焦于患者结局和成本效益。大部分研究是在全面实施之前的受控条件下进行的。似乎缺乏对实施过程及实施情况的评估报告。开展实施研究或将实施措施添加到影响研究中,可增强服务及患者结局的外部效度。实施的各个方面都需要进行评估,包括实施阶段进展的指标(形成性和总结性实施过程评估)、影响因素(障碍和促进因素)的衡量指标以及这些因素随时间的变化(实施影响)、对策略和/或实施计划的评估,以及衡量实施水平的总体指标(实施结果)。专业药学服务的实施水平可根据服务提供的水平(覆盖范围和保真度)以及作为服务提供者的水平(在服务环境中的整合程度和支持力度)来估计。该模型可用于评估专业药学服务以及评估实施计划。